Table 8.
Factors associated with elevated BMI by gender.
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Men | ||||
| GGT (U/L) | ≤20 | 21–29 | 30–43 | ≥44 |
| Cases/subjects at risk | 45/1,178 | 151/1,213 | 228/1,167 | 370/1,206 |
| OR (95% CI: lower–upper) | 1.00 | 2.65 (1.86–3.78) | 3.28 (2.30–4.68) | 4.97 (3.47–7.11) |
| ALT (U/L) | ≤19 | 20–27 | 28–38 | ≥39 |
| Cases/subjects at risk | 72/1,191 | 141/1,201 | 191/1,188 | 390/1,184 |
| OR (95% CI: lower–upper) | 1.00 | 1.49 (1.09–2.03) | 1.68 (1.23–2.29) | 3.17 (2.33–4.32) |
| AST (U/L) | ≤24 | 25–30 | 31–36 | ≥37 |
| Cases/subjects at risk | 116/1,214 | 157/1,294 | 203/1,145 | 318/1,111 |
| OR (95% CI: lower–upper) | 1.00 | 0.86 (0.65–1.13) | 0.96 (0.73–1.28) | 1.00 (0.74–1.35) |
| ALP (U/L) | ≤52 | 53–61 | 62–71 | ≥72 |
| Cases/subjects at risk | 188/1,288 | 194/1,106 | 215/1,202 | 197/1,168 |
| OR (95% CI: lower–upper) | 1.00 | 1.20 (0.94–1.52) | 1.11 (0.88–1.41) | 0.85 (0.67–1.09) |
| Women | ||||
| GGT (U/L) | ≤13 | 14–17 | 18–22 | ≥23 |
| Cases/subjects at risk | 21/1,843 | 42/1,386 | 71/1,151 | 208/1,409 |
| OR (95% CI: lower–upper) | 1.00 | 2.15 (1.26–3.67) | 3.32 (1.99–5.55) | 5.88 (3.56–9.70) |
| ALT (U/L) | ≤13 | 14–18 | 19–23 | ≥24 |
| Cases/subjects at risk | 22/1,480 | 50/1,624 | 80/1,248 | 190/1,437 |
| OR (95% CI: lower–upper) | 1.00 | 1.54 (0.92–2.58) | 2.26 (1.36–3.75) | 2.87 (1.74–4.72) |
| AST (U/L) | ≤22 | 23–26 | 27–31 | ≥32 |
| Cases/subjects at risk | 36/1,451 | 52/1,494 | 97/1,434 | 157/1,410 |
| OR (95% CI: lower–upper) | 1.00 | 0.94 (0.60–1.48) | 1.28 (0.83–1.96) | 1.26 (0.81–1.96) |
| ALP (U/L) | ≤42 | 43–51 | 52–63 | ≥64 |
| Cases/subjects at risk | 36/1,556 | 58/1,352 | 96/1,519 | 152/1,362 |
| OR (95% CI: lower–upper) | 1.00 | 1.38 (0.89–2.15) | 1.56 (0.83–2.37) | 1.75 (0.95–2.68) |
Abbreviations: BMI = body mass index; GGT = gamma-glutamyl transferase; ALT = alanine aminotransferase; AST = aspartate aminotransferase; ALP = alkaline phosphatase; OR = odds ratio; CI = confidence interval.